Best Abstracts: Technology | DES, Imaging Modalities, Biodegradeable Scaffolds, Renal Denervation and Emerging Devices & Innovative Therapies

Moderator(s)

• 

  Kazuhiro Dan, MD, PhD, FACC

  Associate Director of Cardiovascular Medicine, Interventional Cardiologist
  Ichinomiya Nishi Hospital
  Ichinomiya, Aichi, Japan

  No relationships to disclose
• 

  Paul Sapia, MD

  Interventional Cardiologist
  St. Francis Hospital - The Heart Center
  Roslyn, New York, United States

  No relationships to disclose

Presentations:

• 3:00 PM – 3:08 PM ET

  Optical Coherence Tomography Characteristics of the Novel Resorbable Magnesium Scaffold at 6 Months: An Intravascular Imaging Analysis of the First-in-Human Trial on Dreams 3G
  

  Speaker: Masaru Seguchi, MD (he/him/his) – Deutsches Herzzentrum München
• 3:08 PM – 3:12 PM ET

  Panel Discussion
• 3:12 PM – 3:20 PM ET

  Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents In US Patients Undergoing Coronary Revascularization: 1-year Outcomes from the BIOFLOW-VII Trial
  

  Speaker: David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute
• 3:20 PM – 3:24 PM ET

  Panel Discussion
• 3:24 PM – 3:32 PM ET

  Multi-Center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure with Preserved and Reduced Ejection Fraction: Update from the Early Feasibility Alleviate-HF Program
  

  Speaker: Colin Barker, Sr., MD – VUMC
• 3:32 PM – 3:36 PM ET

  Panel Discussion
• 3:36 PM – 3:44 PM ET

  Reproducibility of an Artificial Intelligence Optical Coherence Tomography Software for Tissue Characterization: Implications for the Design of Longitudinal Studies
  

  Speaker: Mohil Garg, MD (he/him/his) – MedStar Washington Hospital Center
• 3:44 PM – 3:48 PM ET

  Panel Discussion
• 3:48 PM – 3:56 PM ET

  Cost-effectiveness of Catheter-based Radiofrequency Renal Denervation for the Treatment of Uncontrolled Hypertension: An Analysis for the UK Based on Recent Clinical Evidence
  

  Speaker: Andrew SP Sharp, MD – University Hospital of Wales
• 3:56 PM – 4:00 PM ET

  Panel Discussion
• 4:00 PM – 4:08 PM ET

  The Prevalence Of Normal Coronary Arteries Amongst Subjects With Diabetes Mellitus
  

  Speaker: Logan Schwarzman, MD – Harbor-UCLA Medical Center
• 4:08 PM – 4:12 PM ET

  Panel Discussion
• 4:12 PM ET

  Adjourn